The Validity and Reliability of the Turkish Version of the CPAQ-8

NCT ID: NCT05252611

Last Updated: 2022-03-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

80 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-01-01

Study Completion Date

2021-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Acceptance of chronic pain is becoming an increasingly important issue in the field of pain management. Many researchers argue that patients who accept pain better function better both physically and psychologically. In many countries, the Chronic Pain Acceptance Questionnaire - 8 (CPAQ-8) has been frequently validated and used to measure the pain acceptance of patients with chronic pain.1 However, the CPAQ-8 has not yet been introduced and validated in Turkey. In this study, we aimed to translate the English version of CPAQ-8 into Turkish, make correct cross-cultural adaptations, and validate the psychometric properties of the Turkish version of CPAQ-8 by testing it in Turkish fibromyalgia patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Chronic pain is an undesirable condition that affects a large part of the society and increases the psychological and economic burden of the population it affects. Psychological variables are known to be strong in the perception of pain and especially cause patients to avoid activity in order to reduce pain. Individuals prefer to avoid painful experiences when they are worn out in repetitive attempts to control and prevent pain, which ultimately causes pain to become more dominant and destructive, and activities that are valuable to the individual are neglected.1 At this point, accepting pain can be seen as the antithesis of avoiding painful experiences. Acceptance of pain is a strong predictor of low disability in chronic pain.2 The Chronic Pain Acceptance Questionnaire (CPAQ) represents one of the ways in which pain acceptance is functionalized and measured in the context of chronic pain. The short form of CPAQ, CPAQ-8, was developed and validated recently and shows the same factor structure, reliability and validity as the 20-factor version. Given that psychometric testing is an incremental process, further evaluation of the questionnaire is desirable, including test-retest reliability and replication of results reported by Fish et al.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Fibromyalgia Chronic Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

CROSS_SECTIONAL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Turkish version of the Chronic Pain Acceptance Questionnaire-8 (CPAQ-8)

The aim of this study is to test the validity of the Turkish version of the Chronic Pain Acceptance Questionnaire-8 (CPAQ-8).

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients who applied to our physical medicine and rehabilitation outpatient clinic,
* Agreed to participate in the study, were over the age of 18,
* Had at least primary school education, were diagnosed with fibromyalgia syndrome according to the 2016 American College of Rheumatology (ACR) criteria,
* Could speak and communicate in Turkish were included in the study.

Exclusion Criteria

* Those who did not agree to participate in the study,
* \<18 years old, and could not communicate in Turkish
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Istanbul University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ahmet Kivanc Menekseoglu

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ahmet K Menekşeoğlu

Role: PRINCIPAL_INVESTIGATOR

Kanuni Sultan Süleyman Research and Training Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ahmet Kıvanç Menekşeoğlu

Istanbul, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

References

Explore related publications, articles, or registry entries linked to this study.

Fish RA, Hogan MJ, Morrison TG, Stewart I, McGuire BE. Willing and able: a closer look at pain Willingness and Activity Engagement on the Chronic Pain Acceptance Questionnaire (CPAQ-8). J Pain. 2013 Mar;14(3):233-45. doi: 10.1016/j.jpain.2012.11.004.

Reference Type BACKGROUND
PMID: 23452647 (View on PubMed)

Fish RA, McGuire B, Hogan M, Morrison TG, Stewart I. Validation of the chronic pain acceptance questionnaire (CPAQ) in an Internet sample and development and preliminary validation of the CPAQ-8. Pain. 2010 Jun;149(3):435-443. doi: 10.1016/j.pain.2009.12.016. Epub 2010 Feb 25.

Reference Type RESULT
PMID: 20188472 (View on PubMed)

Kleinebrecht J, Degenhardt KH, Franz J, Schneider G. Variability of limb malformations induced by 5-fluoro-2'-deoxycytidine in mice. Teratology. 1972 Jun;5(3):295-301. doi: 10.1002/tera.1420050304. No abstract available.

Reference Type RESULT
PMID: 5032639 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2019/58

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.